Lynn Dunsire
BioPharmaceuticals R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of as-needed albuterol-budesonide versus albuterol in patients with asthma aged 12 to <18 years: design of the randomised, double-blind, parallel-group phase IIIb ACADIA trial.
Journal: BMJ open respiratory research
Published: October 03, 2025
As-Needed Albuterol-Budesonide in Mild Asthma.
Journal: The New England journal of medicine
Published: May 19, 2025
Albuterol-budesonide rescue inhaler for asthma: Patterns of use and safety in the MANDALA trial.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: March 13, 2025
Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.
Journal: Therapeutic advances in respiratory disease
Published: May 03, 2024
A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design.
Journal: Journal of asthma and allergy
Published: April 30, 2024
Albuterol-Budesonide Pressurized Metered Dose Inhaler in Patients With Mild-to-Moderate Asthma: Results of the DENALI Double-Blind Randomized Controlled Trial.
Journal: Chest
Published: November 30, 2022
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
Journal: The New England journal of medicine
Published: May 15, 2022
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD.
Journal: Pulmonary pharmacology & therapeutics
Published: February 13, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026